Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTX-A Injection for Equinovarus Deformity in Unilateral Cerebral Palsy (Children)
KCT0000530Phase 4Not yet recruiting
- Sponsor
- Medytox Inc.
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in cerebral palsy (CP) and Congenital talipes equinovarus (CTEV), sponsored by Medytox Inc. Planned start Sep 2012; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)Congenital talipes equinovarus (CTEV)
Beyond the preview
Go deeper on KCT0000530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000530.